Full Text
Forecasting The Health And Health Spending Consequences Of Value-Based Drug Insurance Design For Insureds With Five High-Cost Conditions

Abstract

Authors

N. Olchanski A.S. Milstein J.D. Chambers P.J. Neumann

Back to Volume 16, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×